SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

12 Feb 2025 Evaluate
The total revenue for the quarter ended December 2024 remained nearly unchanged at Rs. 1227.52 millions.The Company has registered profit of Rs. 192.45  millions for the quarter ended December 2024, a growth of 10.28%  over Rs. 174.51 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended December 2024 rose to 277.09 millions as compared to 253.38 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1227.52 1169.94 4.92 3164.03 2941.69 7.56 4212.30 3796.36 10.96
Other Income 43.60 37.64 15.83 128.59 113.98 12.82 163.48 145.42 12.42
PBIDT 277.09 253.38 9.36 533.58 469.72 13.60 681.59 589.34 15.65
Interest 0.56 0.54 3.70 1.76 1.08 62.96 1.57 0.77 103.90
PBDT 276.53 252.84 9.37 531.82 468.64 13.48 680.02 588.57 15.54
Depreciation 16.64 15.76 5.58 49.04 45.22 8.45 60.57 52.12 16.21
PBT 259.89 237.08 9.62 482.78 423.42 14.02 619.45 536.45 15.47
TAX 67.44 62.57 7.78 126.22 110.28 14.45 169.73 138.10 22.90
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 192.45 174.51 10.28 356.56 313.14 13.87 449.72 398.35 12.90
Equity 28.91 28.91 0.00 28.91 29.23 -1.09 28.91 29.23 -1.09
PBIDTM(%) 22.57 21.66 4.23 16.86 15.97 5.61 16.18 15.52 4.23

Amrutanjan Healthcar Share Price

546.50 7.85 (1.46%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×